The official drugs, ramipril: 4-[2-(1-ethoxycarbonyl-3-phenyl-propyl)aminopropionyl]-4-aza bicyclo[3.3.0]octane-3-carboxylic acid and enalapril maleate: 1-[2-(1-ethoxycar-bonyl-3-phenyl-propyl)aminopropionyl]pyrrolidine-2-car-boxylic acid and the non official fosinopril: 4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxy-propoxy)-(4-phenylbutyl)-phosphoryl]acetyl]-pyrrolidine-2-carboxylic acid are antihy-pertensive agents which their metabolites are active in-hibitors of angiotensin-converting enzyme (ACE); inhibition of ACE results in decreased plasma angiotensin II which leads to decreased vasopressor activity. 1) Ramipril and enalapril maleate are official in B.P. 2) and enalapril maleate is official in USP 24, 3) while fosinopril is unofficial in any phar-macopoeia. Various analytical methods have been reported for the assay of the cited drugs in their pure forms as well as in pharmaceutical formulations. They include for ramipril, a kinetic spectrophotometry, 4) spectrophotometry and atomic absorption , 5) fluorimetry, 6) HPLC, 7) bioavailability assessment of nanoemulsion, 8) reversed-phase HPLC, 9) and liquid chromatography mass spectrometry. 10) For enalapril, spectropho-tometry using chelate formation with palladium(II) chloride , 11) spectrophotometry in the presence of its photo degradation products, 12) quantitative 1 H-NMR spectroscopy, 13) second derivative ultraviolet spectrophotometry, 14) HPLC in the presence of the major active metabolite enalaprilate, 15) linear regression analysis and its application to multivariate chro-matographic calibration, 16) HPTLC, 17) radio-immunoassay, 18) potentiometric titration 19) and differential pulse polarography (DPP). 20) For fosinopril with H 2-receptor antagonists by derivative spectroscopy, 21) UV and third derivative spectropho-tometry, 22) microemulsion liquid chromatography, 23) HPLC in the presence of its degradation product fosinoprilate, 24) TLC procedures 25) and reversed-phase ion-pair liquid chromatography. 26) Several colorimetric methods for determination of some drugs in pharmaceutical preparations using molybdenum (V) (Mo(V)) thiocyanate reagent forming ion-pair complex were reported such as; chloroquine and pyrimethamine, 27) ampi-cillin, dicloxacillin, flucloxacillin and amoxacillin, 28) some piperazine derivatives, 29) trazodone, amineptine and amitriptyline hydrochloride, 30) metoclopramide and oxybup-rocaine, 31) and some H 1-antihistaminics. 32) Although the chromatographic methods are sensitive enough, they are expensive and not easily manageable. On the other hand; spectrophotometry is still the technique of Three different sensitive and accurate spectroscopic procedures were developed for the determination of three angiotensin-converting enzyme inhibitors, namely, ramipril, enalapril maleate and fosinopril. The first two spectrophotometric (extractive and non-extractive) procedures were based on ternary complex formation with molybdenum(V) thiocyanate. The formed complex can be determined by extraction with chloroform measured at l l max 517 nm Beer's law was obeyed in the concentration range from (10-90 m mg ml ؊1) for ramipril and fosino-pril and (4-36 m mg ml ؊1) for enalapril maleate with molar absorptivity 1.2؋10 4 , 2؋10 4 and 3.4؋10 4 l mol ؊1 cm ؊1 , respectively, or by direct measurement after addition of benzalkonium chloride as surfactant and measuring the formed ternary complex at l l max 545 nm with a linear relationship in the concentration range from (8-72 m mg ml ؊1), (3-27 m mg ml ؊1) and (8-72 m mg ml ؊1) for ramipril, enalapril maleate and fosinopril with molar ab-sorptivity 1.5؋10 4 , 5؋10 4 and 2.1؋10 4 l mol ؊1 cm ؊1 , respectively. The third procedure is atomic absorption measurement through the quantitative determination of molybdenum content of the complex. These methods hold their accuracy and precision well when applied to the determination of ramipril, enalapril maleate and fosinopril in their dosage forms.